(19)

(11)

EP 4 355 285 A2

(12)

(88) Date of publication A3: 02.02.2023 (43) Date of publication: 24.04.2024 Bulletin 2024/17 (21) Application number: 22735143.4 (22) Date of filing: 17.06.2022

(51) International Patent Classification (IPC):  A61J 7/04(2006.01) A61M 35/00(2006.01) G06T 7/00(2017.01) A61B 5/107(2006.01) G16H 20/13(2018.01) A61B 5/00(2006.01) A45D 44/00(2006.01) (52) Cooperative Patent Classification (CPC): A61J 7/0418; A61J 7/0481; G16H 20/13; A61M 35/00; A61B 5/445; G06T 7/0012; A61B 5/441; A61B 5/7485; A45D 2044/007; G16H 40/63; G06T 2207/10024; G06T 2207/30088; A61B 5/4833; A61B 5/0077; A61B 2576/00; A61B 5/6898; A61B 5/002; A61J 7/0076; A61J 2200/30; A61J 2200/70; A61J 7/0436; A45D 2034/002; A45D 34/00 (86) International application number: PCT/EP2022/066537 (87) International publication number: WO 2022/263622 (22.12.2022 Gazette 2022/51)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 18.06.2021 CH 7122021 (71) Applicant: Merz Pharma (Schweiz) AG 4123 Allschwil (CH)	(72) Inventor: WILDI, Eckhart 4102 Binningen (CH) (74) Representative: Latscha Schöllhorn Partner AG  Grellingerstrasse 60 4052 Basel 4052 Basel (CH)